Search Results - "McGinn, Arlo N"
-
1
Feeding Tube Placement: Errors and Complications
Published in Nutrition in clinical practice (01-12-2012)“…Feeding tube placement for enteral nutrition (EN) support is widely used in both critically ill and stable chronically ill patients who are unable to meet…”
Get full text
Journal Article -
2
Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia
Published in Biomaterials (01-08-2013)“…Abstract Vascular endothelial growth factor (VEGF) gene therapy to promote therapeutic angiogenesis has been advanced as an alternative treatment for…”
Get full text
Journal Article -
3
Targeted Gene Delivery to Ischemic Myocardium by Homing Peptide-Guided Polymeric Carrier
Published in Molecular pharmaceutics (07-01-2013)“…Myocardial ischemia needs an alternative treatment such as gene therapy for the direct protection of cardiomyocytes against necrosis or apoptosis and to…”
Get full text
Journal Article -
4
Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats
Published in Journal of controlled release (10-10-2013)“…Considerable efforts have been made to exploit cardioprotective drugs and gene delivery systems for myocardial infarction (MI). The promising cardioprotective…”
Get full text
Journal Article -
5
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium
Published in Biomaterials (01-01-2011)“…Abstract Implantation of skeletal myoblasts to the heart has been investigated as a means to regenerate and protect the myocardium from damage after myocardial…”
Get full text
Journal Article -
6
Abstract 2756: Synergistic tumor-suppressive effect of apatinib, a selective VEGFR-2 inhibitor, in combination with immunotherapy in a syngeneic murine lung cancer model
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Anti-angiogenesis therapy is considered one of several promising combination strategies with immunotherapy. The potential for synergistic combination is based…”
Get full text
Journal Article -
7
A phase I study to evaluate the pharmacokinetics of a new oncology nce, apatinib mesylate tablets, with and without food following single and multiple doses in healthy subjects
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e14049 Background: Apatinib Mesylate (YN968D1) is a selective inhibitor of VEGFR-2 being developed for the treatment of advanced gastric cancer…”
Get full text
Journal Article -
8
Phase I study to evaluate the safety and efficacy of rivoceranib (apatinib) and nivolumab in patients with unresectable or metastatic cancer
Published in Journal of clinical oncology (10-03-2019)“…Abstract only 18 Background: Due to their immuno-modulatory effects, anti-angiogenic drugs have been clinically investigated in combination with anti-PD-1…”
Get full text
Journal Article -
9
A prospective, randomized, double-blinded, placebo-controlled, phase III study to evaluate the efficacy and safety of apatinib plus best supportive care (BSC) compared to placebo plus BSC in patients with advanced or metastatic gastric cancer: The ANGEL study
Published in Journal of clinical oncology (20-05-2017)“…Abstract only TPS4138 Background: Apatinib is an orally administered, highly selective tyrosine kinase inhibitor of VEGFR-2 that has been studied in many…”
Get full text
Journal Article -
10
Human Erythropoietin Gene Delivery for Cardiac Remodeling of Myocardial Infarction in Rats
Published in Molecular therapy (01-09-2013)“…Background: Considerable efforts have been made to exploit cardioprotective drugs and gene delivery systems for myocardial infarction. The promising…”
Get full text
Journal Article -
11
Feeding Tube Placement
Published in Nutrition in clinical practice (01-12-2012)“…Feeding tube placement for enteral nutrition (EN) support is widely used in both critically ill and stable chronically ill patients who are unable to meet…”
Get full text
Journal Article